Your browser doesn't support javascript.
loading
Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release.
Du, Jianjun; Zhang, Yu; Ge, Haoying; Shi, Chao; Long, Saran; Sun, Wen; Fan, Jiangli; Peng, Xiaojun.
Affiliation
  • Du J; State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China. dujj@dlut.edu.cn.
Chem Commun (Camb) ; 56(54): 7503-7506, 2020 Jul 11.
Article in En | MEDLINE | ID: mdl-32501465
ABSTRACT
In this work, bovine serum albumin-based nanoparticles, BSA-ACVA-DOX NPs, were fabricated for ultrasound-driven drug release, and exhibited excellent tissue penetration. Moreover, a pulsatile release of DOX in vivo could be programmed by in vitro (i.e., remotely) switching the ultrasound on and off.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serum Albumin, Bovine / Doxorubicin / Nanoparticles Limits: Animals / Humans Language: En Journal: Chem Commun (Camb) Journal subject: QUIMICA Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serum Albumin, Bovine / Doxorubicin / Nanoparticles Limits: Animals / Humans Language: En Journal: Chem Commun (Camb) Journal subject: QUIMICA Year: 2020 Document type: Article Affiliation country: